Global Artificial Intelligence in Healthcare Market

Global Artificial Intelligence in Healthcare Market Size Estimation, Share & Future Growth Trends Analysis, By Type of AI (Machine Learning, Natural Language Processing, Rule-based Expert Systems, Physical Robots, and Robotic Process Automation), By Application (Robot-Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, and Others), By Component, By End User, and Regional Analysis, 2022-2030

Region : Global | Format : PDF, Excel | Report ID : QR-120292 Share

Buy Now Download Free Sample Now

Frequently Asked Questions

The global artificial intelligence in healthcare market is predicted to develop at a compound annual growth rate of 36.78% from 2022-2030 to reach up to USD xx billion by 2030.

The global artificial intelligence in healthcare market was valued at USD xx billion in 2020 and is expected to reach USD xx billion in 2021.

North America dominated the market, accounting for about xx % of the global market in 2021. The high number of startups in the region and the high adoption of AI is contributing factor to the market growth in the region.

Some of the key market players operating in the artificial intelligence in healthcare market are Welltok, Inc., Microsoft Corporation, Intel Corporation, Google Inc., Enlitic, Inc., IBM Corporation, General Vision, Inc., Nvidia Corporation, Next IT Corporation, and iCarbonX.

The high prevalence of diseases and rising awareness of AI in the population are the key drivig factors. Government initiatives to increase the use of AI and the introduction of 5G are also contributing to the development of the market in the near future. Additionally, the market for artificial intelligence in healthcare is anticipated to grow as a result of the increasing potential of AI-based tools for elderly care, the increased focus on creating human-aware AI systems, the growing potential of AI technology in drug discovery, genomics, and diagnostics & imaging to combat COVID-19.